[Cytoreductive surgery as an alternative to palliative operations in oncology (the model of treatment of stage IV colorectal cancer)].
Based on an analysis of treatment of patients with colorectal cancer of the IV stage in two groups of patients by the method of cytoreductive technology (58 patients) compared with a group (64 patients) treated using palliate operations, the author makes a conclusion that cytoreductive operations are an alternative to palliative interventions since they give longer survival and save quality of life. The adjuvant immunochemotherapy is thought to be a necessary component of cytoreductive operations.
Grinev
M V
MV
D000230:Adenocarcinoma / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000601:surgery* / Q000628:therapy; D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D003106:Colon / Q000473:pathology; D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000601:surgery* / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D002955:Leucovorin / Q000008:administration & dosage / Q000627:therapeutic use; D007978:Levamisole / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D009362:Neoplasm Metastasis; D010166:Palliative Care; D011788:Quality of Life; D012007:Rectum / Q000473:pathology; D013997:Time Factors
D000276:Adjuvants, Immunologic; D000964:Antimetabolites, Antineoplastic; D007978:Levamisole; D002955:Leucovorin; D005472:Fluorouracil